Advanced Pulmonary Physiomic Imaging Laboratory (APPIL)
Led by Eric Hoffman, PhD, APPIL seeks to broaden the understanding of basic physiology and pathophysiology of the lung along with pulmonary disease co-morbidities using quantitative imaging.
Functional Pulmonary MRI Laboratory
Led by Sean Fain, PhD
Magnetic Resonance Research Facility (MRRF)
Led by Vince Magnotta, PhD, MRRF provides research dedicated 3.0T and 7.0T MR imaging equipment and expertise for over 60 research projects that span over a dozen departments and across five UI colleges.
Medical Image Perception Laboratory (MIPL)
Led by Claudia Mello-Thoms, PhD, MIPL investigates the human component of image interpretation to reduce diagnostic error in Radiology, done so by improving imaging technology so that reads are able to be better identified, as well as studies the perceptual and intellectual aspects of how physicians interpret images.
Multiparametric Quantitative MRI Group
Led by Xi Peng, PhD, the Multiparametric Quantitative MRI Group is dedicated to the development of cutting-edge task-driven neuroimaging technologies that yield dependable biomarkers to advance comprehension of brain functions and diseases.
Positron Emission Tomography (PET) Laboratory
Led by John Sunderland, PhD, focuses on the use of PET imaging for both animal and human studies. Including the use of novel radiotracers in imaging, the modality allows for detection of various cancer and brain-focused diseases such as Alzheimer’s Disease.
Radiology Core Lab (RCL)
Led by Jessica Sieren, PhD, the RCL provides a comprehensive set of quantitative imaging services for oncologic clinical trials, radiologic expertise for image-based protocols and analysis design and precise tumor measurements.
Small Animal Imaging Core (SAIC)
Led by Thad Wadas, PhD, specializes in the use of a variety of imaging modalities to understand how disease impacts animals ranging from small animals including mice and rats, to larger animals such as ferrets and pigs.
The Wadas Laboratory
Led by Thad Wadas, PhD, combines novel ligand discovery techniques with innovative radiochemistry strategies to develop radiopharmaceutical solutions that can be implemented to detect and treat a variety of diseases including cancer, cardiovascular disease, arthritis and Alzheimer’s disease.